Previous 10 | Next 10 |
R1 RCM ( NASDAQ: RCM ) is scheduled to announce Q4 earnings results on Thursday, February 16th, before market open. The consensus EPS Estimate is $0.04 (-63.6% Y/Y) and the consensus Revenue Estimate is $519.28M (+30.2% Y/Y). Over the last 1 year, RCM has beaten EPS estimate...
MURRAY, Utah, Feb. 08, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, announced today that R1 and Cloudmed, an R1 company, we...
MURRAY, Utah, Jan. 26, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months and fu...
Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Investors are eager to herald a return to low inter...
MURRAY, Utah, Jan. 05, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment...
Summary 2022 was yet another crazy year around the world following another crazy year, the stock market being no exception. I recap some of the research I presented over the year, and some other ideas and strategies I’ve been experimenting with. Update on my personal investin...
MURRAY, Utah, Dec. 22, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 41st Annual J.P. Morgan Hea...
Summary Repositioning cross-asset and equity-focused portfolios has been a challenging affair in the latter half of FY22. Such has been the case for longs of MD, where the investment debate how now is negatively skewed to the downside. MD is faced with a series of hurdles to ramp up...
Shares of R1 RCM (NASDAQ: RCM) rose 10% on Tuesday. The stock closed at $7.51 on Monday, then opened on Tuesday at $7.52. It rose to a daily high of $8.31 shortly after 2 p.m. ET before closing at $8.25. The stock has a 52-week low of $6.71 and a 52-week high of $27.86 and is down m...
SAN FRANCISCO, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges R1 RCM Inc. (NASDAQ: RCM) investors who suffered significant losses to submit your losses now . Visit: https://www.hbsslaw.com/investor-fraud/RCM Contact An Attorney Now: RCM@hbsslaw.com ...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...
2024-07-08 09:30:06 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for RCM on July 8, 2024 07:50AM ET. The previous analyst recommendation was Overweight. RCM was trading at $10.95 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...